Xuetao Chen

发表

Dynamic scaling of hysteresis dispersion in ferroelectrics

B. Pan, J. Liu, H. Yu, 2005 .

Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines.

Xuechu Zhen, Xuechu Zhen, Zhili Liu, 2008, Bioorganic & medicinal chemistry.

Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand

Xuechu Zhen, Hai Zhang, Jianjun Cheng, 2009, Schizophrenia Research.

A JAK tyrosine kinase and pseudokinase Co-inhibition strategy combines enhanced potency and on-demand activation.

Q. You, Zhengyu Jiang, Qi-chao Bao, 2023, European journal of medicinal chemistry.

Targeting m6A binding protein YTHDFs for cancer therapy.

W. Kang, Zhengyu Jiang, Qidong You, 2023, Bioorganic & medicinal chemistry.

Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain.

Wenjing Kang, B. Xiong, D. Cao, 2023, Journal of medicinal chemistry.

Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.

Xuechu Zhen, A. Zhang, Jing Zhang, 2008, Bioorganic & medicinal chemistry.

N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.

Xuechu Zhen, Zhili Liu, A. Zhang, 2008, Bioorganic & medicinal chemistry.

Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis.

Zhengyu Jiang, Qi-chao Bao, R. Xu, 2023, European journal of medicinal chemistry.

Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8.

Zhengyu Jiang, Qidong You, Tingting Wu, 2024, European journal of medicinal chemistry.